Environment Topics

The On-Topic Netowork

Environment > Administered Dose


Administered Dose
Administered Dose
Administered Dose
Administered Dose
Administered Dose

The following information is about Administered Dose.

Administered Dose Defined

In exposure assessment, the amount of a substance given to a test subject (human or animal) to determine dose-response relationships. Since exposure to chemicals is usually inadvertent, this quantity is often called potential dose.

This definition is in context to Environment. See more contextual defintions for Administered Dose.


Navigation: [ 1 2 3 4 5 Next ]

Phase III U.S. Pivotal Study Results On CSL Biotherapies' Afluria® Published In Vaccine - Influenza Virus Vaccine

Published September 5, 2008, 7:16 am, Medical News Today

Phase III pivotal study findings in the journal Vaccine showed that two formulations of CSL Biotherapies' influenza virus vaccine Afluria® elicited an immune response (also known as immunogenicity) in healthy adults aged 18 - About the Phase III Study The pivotal study was a National Institutes

Full Story


LUNESTA(R) Next-Day Function And Discontinuation Data From A Long-Term 12-Week Study In Elderly Patients Presented At ...

Published September 5, 2008, 7:15 am, Medical News Today

Sepracor Inc. (Nasdaq: SEPR) announced the presentation of LUNESTA ® brand eszopiclone Phase IV study data at the 21st European College of Neuropsychopharmacology (ECNP) Congress in Barcelona.

Full Story


First Guiding Catheter To Successfully Enable Administration Of Medicine Directly To The Coronary Artery Throughout ...

Published September 5, 2008, 7:15 am, Medical News Today

Hadasit, the technology transfer company of Hadassah Medical Organization, announced today the successful pre-clinical testing of a prototype of the Double Lumen PCI Guiding Catheter for use in the treatment of coronary artery disease. Unlike today's conventional catheters, the Double Lumen PCI Guiding Catheter has two lumens rather than one.

Full Story


QuatRx Initiates Second Phase 3 Study Of Ophena(TM) (Ospemifene Tablets) In Women With Postmenopausal Vaginal Syndrome

Published September 5, 2008, 7:14 am, Medical News Today

QuatRx Pharmaceuticals, a privately-held biopharmaceutical company focused on development and commercialization of compounds to treat endocrine, metabolic and cardiovascular disorders, announced that it has initiated a second Phase 3 clinical trial of Ophena(TM) (ospemifene tablets), the com

Full Story


BioCryst Reports Results From BCX-4208 Phase IIa Trial In Subjects With Psoriasis

Published September 5, 2008, 7:14 am, Medical News Today

BioCryst Pharmaceuticals (Nasdaq: BCRX) announced results from the completed Phase IIa trial of BCX-4208 in patients with moderate to severe plaque psoriasis.

Full Story


District, state remind parents of the importance of vaccinations

Published September 5, 2008, 6:34 am, Casper Star-Tribune

Vaccination rates for children in Wyoming have increased, but students in Natrona County School District still return to school with incomplete immunization records.

Full Story


Cytopia Commences Second Phase II Study In Brain Cancer

Published September 5, 2008, 3:14 am, Medical News Today

Cytopia Limited (ASX:CYT) announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM).

Full Story


Cigarettes' Power May Not be in Nicotine Itself but in How It Enhances Other Experiences While Smoking

Published September 5, 2008, 2:22 am, Kansas City InfoZine

There may be a very good reason why coffee and cigarettes often seem to go hand in hand.

Full Story


CSL Biotherapies Announces First Shipments of Afluria(R) Thimerosal-Free Influenza Vaccine for the 2008-2009 Flu Season

Published September 4, 2008, 8:12 pm, Centre Daily Times

CSL Biotherapies, a subsidiary of one of the world's leading manufacturers of influenza vaccine, announced today that it has begun shipment of its influenza virus vaccine in the U.S. for the 2008-2009 season. CSL plans to deliver more than six million doses of Afluria and the majority of the supply will be in single-dose, thimerosal-free, pre-filled syringes.

Full Story


CSL Biotherapies Announces First Shipments of Afluria(R) Thimerosal-Free Influenza Vaccine for the 2008-2009 Flu Season

Published September 4, 2008, 3:25 pm, wallstreet:online AG

CSL Biotherapies, a subsidiary of one of the world´s leading manufacturers of influenza vaccine,

Full Story


Navigation: [ 1 2 3 4 5 Next ]

Are you looking for additional Environment > Administered Dose news? Try our new "Administered Dose News Focus" area.

Social bookmarks are not available at the moment.

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Administered Dose. If you would like to find related tags we recommend Tag Patterns > Administered Dose

Off-site Administered Dose Research Links

If you still need additional information on Administered Dose then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Environment

If you know the Environment Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Environment.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a